Prof. Dr. Peter Dabrock

Chair for Systematic Theology (Ethics)

The research profile of the Chair of Systematic Theology II (Ethics) at the FAU can be characterized as foundational-theological and concrete ethics and includes in particular questions concerning bioethics and social ethics. Ethics is conceived as a discipline that detects normative questions and analyses and interprets them in regarding prerequisites and consequences, determines criteria for the assessment of conflict situations and thus also advises decision-makers at the same time, and passes on the respective knowledge and competencies to students. Peter Dabrock’s current research focuses on ethics of life sciences and biomedicine at the interface of science, technology, and society, ethics of Big Data-driven and biomarker-based medicine, ethics of AI, ethics of Pandemic response, and ethics of forms of life in the democratically framed civil society under the rule of law (social justice, demographic change, sexual ethics, public theology).

Research projects

  • VALID: Al-Driven Decision-Making in the Clinic. Ethical, Legal, and Societal Challenges
  • DigiOnko: Integrative concept for personalized precision medicine in prevention, early detection, therapy, and relapse avoidance using the example of breast cancer
  • DABIGO: data sovereignty in clinical big data regimes. Ethical, Legal, and Governance Challenges

  • Erarbeiten ethischer Leitlinien für den Einsatz von KI-Prognosemodellen zur geschlechtsspezifischen Risikobestimmung

    (Third Party Funds Group – Sub project)

    Overall project: Diagnose des geschlechtsspezifischen Risikos fürKrebserkrankungen bei nierentransplantierten Patient:innen durch KI-Prognosemodelle
    Term: 1. November 2025 - 31. October 2028
    Funding source: Bundesministerium für Forschung, Technologie und Raumfahrt (BMFTR)
    URL: https://gege4nephro.eu/
    Approx. 100,000 people in Germany live with chronic kidney disease and require regular dialysis and, in the long term, an organ transplant. Their care accounts for more than ten percent of healthcare expenditure. Kidney transplant recipients have a higher risk of cancer than the general population. Gender-specific differences in diagnosis, therapy, and aftercare are still not taken into account sufficiently. For example, women have up to a 20 percent lower chance of getting on the waiting list for a donor kidney, despite having a comparable or better prognosis after transplantation than men.
    The goal of GeGe4Nephro is to develop an AI-supported prognosis model that helps physicians better assess the individual risk of complications after a kidney transplant, such as cancer, and to recommend personalized preventive measures, such as targeted skin cancer screenings.The GeGe4Nephro consortium combines all relevant expertise for this purpose. The Charité – Universitätsmedizin Berlin (CHA) and the Universitätsklinikum Leipzig (UKL) contribute clinical expertise and transplant data, the Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) is responsible for ethical guidelines, and the Hasso Plattner Institute for Digital Engineering (HPI) contributes AI methodological expertise. Justus Liebig University Giessen (JLU) and Labor Pachmann GmbH contribute state-of-the-art epi/genetic and molecular laboratory expertise. In addition, the consortium has a broad network of international partners consisting of – amongst others – patient and physician representatives, transplant centers, research, and industry representatives.GeGe4Nephro aims to build an innovative tool for gender-specific, data-based medicine that sustainably optimizes the follow-up care of kidney transplant patients.

2025

2024

2023

2022

2021

2020

Related Research Fields

Contact: